Calcium Phosphate Nanoparticles Functionalized with a Cardio-Specific Peptide

Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, highliting the urgent need for new therapeutic strategies. Peptide-based therapies have demonstrated significant potential for treating CVDs; however, their clinical application is hindered by their limited stability in...

Full description

Saved in:
Bibliographic Details
Main Authors: Federica Mancini, Lorenzo Degli Esposti, Alessio Adamiano, Jessica Modica, Daniele Catalucci, Dora Mehn, Otmar Geiss, Michele Iafisco
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Nanomaterials
Subjects:
Online Access:https://www.mdpi.com/2079-4991/15/2/94
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587800328798208
author Federica Mancini
Lorenzo Degli Esposti
Alessio Adamiano
Jessica Modica
Daniele Catalucci
Dora Mehn
Otmar Geiss
Michele Iafisco
author_facet Federica Mancini
Lorenzo Degli Esposti
Alessio Adamiano
Jessica Modica
Daniele Catalucci
Dora Mehn
Otmar Geiss
Michele Iafisco
author_sort Federica Mancini
collection DOAJ
description Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, highliting the urgent need for new therapeutic strategies. Peptide-based therapies have demonstrated significant potential for treating CVDs; however, their clinical application is hindered by their limited stability in physiological fluids. To overcome this challenge, an effective drug delivery system is essential to protect and efficiently transport peptides to their intended targets. This study introduces two distinct strategies for loading a cardio-specific mimetic peptide (MP), previously designed to modulate L-type calcium channel function in cardiomyocytes, onto calcium phosphate nanoparticles (CaP NPs). MP-loaded CaP NPs were prepared by two different wet precipitation syntheses, one of which involved the use of sodium polyacrylate as a templating agent. Characterization of MP-loaded CaP NPs showed that their crystallinity, size, surface charge, and morphology could be tuned by adjusting the synthesis parameters. In vitro tests on cardiac cells confirmed that both types of MP-loaded CaP NPs are biocompatible with HL-1 cardiomyocytes and restored intracellular calcium flux under stressed conditions, highlighting their therapeutic potential. These results pave the way for further optimization of CaP NP formulations and suggest their potential as a viable nanomaterial for CVD treatment.
format Article
id doaj-art-674429fd783946ab8024f9627a52989e
institution Kabale University
issn 2079-4991
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Nanomaterials
spelling doaj-art-674429fd783946ab8024f9627a52989e2025-01-24T13:44:07ZengMDPI AGNanomaterials2079-49912025-01-011529410.3390/nano15020094Calcium Phosphate Nanoparticles Functionalized with a Cardio-Specific PeptideFederica Mancini0Lorenzo Degli Esposti1Alessio Adamiano2Jessica Modica3Daniele Catalucci4Dora Mehn5Otmar Geiss6Michele Iafisco7Institute of Science, Technology and Sustainability for Ceramics (ISSMC), National Research Council (CNR), 48018 Faenza, ItalyInstitute of Science, Technology and Sustainability for Ceramics (ISSMC), National Research Council (CNR), 48018 Faenza, ItalyInstitute of Science, Technology and Sustainability for Ceramics (ISSMC), National Research Council (CNR), 48018 Faenza, ItalyIRCCS Humanitas Research Hospital, Humanitas Cardio Center, 20089 Rozzano, ItalyIRCCS Humanitas Research Hospital, Humanitas Cardio Center, 20089 Rozzano, ItalyEuropean Commission, Joint Research Center (JRC), 21027 Ispra, ItalyEuropean Commission, Joint Research Center (JRC), 21027 Ispra, ItalyInstitute of Science, Technology and Sustainability for Ceramics (ISSMC), National Research Council (CNR), 48018 Faenza, ItalyCardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, highliting the urgent need for new therapeutic strategies. Peptide-based therapies have demonstrated significant potential for treating CVDs; however, their clinical application is hindered by their limited stability in physiological fluids. To overcome this challenge, an effective drug delivery system is essential to protect and efficiently transport peptides to their intended targets. This study introduces two distinct strategies for loading a cardio-specific mimetic peptide (MP), previously designed to modulate L-type calcium channel function in cardiomyocytes, onto calcium phosphate nanoparticles (CaP NPs). MP-loaded CaP NPs were prepared by two different wet precipitation syntheses, one of which involved the use of sodium polyacrylate as a templating agent. Characterization of MP-loaded CaP NPs showed that their crystallinity, size, surface charge, and morphology could be tuned by adjusting the synthesis parameters. In vitro tests on cardiac cells confirmed that both types of MP-loaded CaP NPs are biocompatible with HL-1 cardiomyocytes and restored intracellular calcium flux under stressed conditions, highlighting their therapeutic potential. These results pave the way for further optimization of CaP NP formulations and suggest their potential as a viable nanomaterial for CVD treatment.https://www.mdpi.com/2079-4991/15/2/94cardiovascular diseasescalcium phosphatenanoparticlestherapeutic peptidesdrug delivery
spellingShingle Federica Mancini
Lorenzo Degli Esposti
Alessio Adamiano
Jessica Modica
Daniele Catalucci
Dora Mehn
Otmar Geiss
Michele Iafisco
Calcium Phosphate Nanoparticles Functionalized with a Cardio-Specific Peptide
Nanomaterials
cardiovascular diseases
calcium phosphate
nanoparticles
therapeutic peptides
drug delivery
title Calcium Phosphate Nanoparticles Functionalized with a Cardio-Specific Peptide
title_full Calcium Phosphate Nanoparticles Functionalized with a Cardio-Specific Peptide
title_fullStr Calcium Phosphate Nanoparticles Functionalized with a Cardio-Specific Peptide
title_full_unstemmed Calcium Phosphate Nanoparticles Functionalized with a Cardio-Specific Peptide
title_short Calcium Phosphate Nanoparticles Functionalized with a Cardio-Specific Peptide
title_sort calcium phosphate nanoparticles functionalized with a cardio specific peptide
topic cardiovascular diseases
calcium phosphate
nanoparticles
therapeutic peptides
drug delivery
url https://www.mdpi.com/2079-4991/15/2/94
work_keys_str_mv AT federicamancini calciumphosphatenanoparticlesfunctionalizedwithacardiospecificpeptide
AT lorenzodegliesposti calciumphosphatenanoparticlesfunctionalizedwithacardiospecificpeptide
AT alessioadamiano calciumphosphatenanoparticlesfunctionalizedwithacardiospecificpeptide
AT jessicamodica calciumphosphatenanoparticlesfunctionalizedwithacardiospecificpeptide
AT danielecatalucci calciumphosphatenanoparticlesfunctionalizedwithacardiospecificpeptide
AT doramehn calciumphosphatenanoparticlesfunctionalizedwithacardiospecificpeptide
AT otmargeiss calciumphosphatenanoparticlesfunctionalizedwithacardiospecificpeptide
AT micheleiafisco calciumphosphatenanoparticlesfunctionalizedwithacardiospecificpeptide